Liminal BioSciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch LMNL and buy or sell other stocks, ETFs, and their options commission-free!About LMNL
Liminal BioSciences, Inc. operates as a clinical stage biopharmaceutical company. The firm focuses on developing distinctive novel small molecule therapeutics for inflammatory, fibrotic, and metabolic diseases using drug discovery platform and a data driven approach.
CEOBruce Philip Pritchard
CEOBruce Philip Pritchard
Employees—
Employees—
HeadquartersLaval, Québec
HeadquartersLaval, Québec
Founded1994
Founded1994
Employees—
Employees—
LMNL Key Statistics
Market cap19.82M
Market cap19.82M
Price-Earnings ratio27.62
Price-Earnings ratio27.62
Dividend yield—
Dividend yield—
Average volume16.36K
Average volume16.36K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$8.50
52 Week high$8.50
52 Week low$3.10
52 Week low$3.10
Stock Snapshot
As of today, Liminal BioSciences(LMNL) shares are valued at $8.50. The company's market cap stands at 19.82M, with a P/E ratio of 27.62.
During the trading day, Liminal BioSciences(LMNL) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Liminal BioSciences(LMNL) stock has reached 0, versus its average volume of 16.36K.
Over the past 52 weeks, Liminal BioSciences(LMNL) stock has traded between a high of $8.50 and a low of $3.10.
Over the past 52 weeks, Liminal BioSciences(LMNL) stock has traded between a high of $8.50 and a low of $3.10.
People also own
Based on the portfolios of people who own LMNL. This list is generated using Robinhood data, and it’s not a recommendation.